| Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial J Bruix, S Qin, P Merle, A Granito, YH Huang, G Bodoky, M Pracht, ... The Lancet 389 (10064), 56-66, 2017 | 3657 | 2017 |
| Clinical patterns of hepatocellular carcinoma in nonalcoholic fatty liver disease: a multicenter prospective study F Piscaglia, G Svegliati‐Baroni, A Barchetti, A Pecorelli, S Marinelli, ... Hepatology 63 (3), 827-838, 2016 | 608 | 2016 |
| Field‐practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multicenter study in Italy M Iavarone, G Cabibbo, F Piscaglia, C Zavaglia, A Grieco, E Villa, ... Hepatology 54 (6), 2055-2063, 2011 | 424 | 2011 |
| Outcomes of sequential treatment with sorafenib followed by regorafenib for HCC: Additional analyses from the phase III RESORCE trial RS Finn, P Merle, A Granito, YH Huang, G Bodoky, M Pracht, O Yokosuka, ... Journal of Hepatology 69 (2), 353-358, 2018 | 360 | 2018 |
| Antiendomysial and antihuman recombinant tissue transglutaminase antibodies in the diagnosis of coeliac disease: a biopsy-proven European multicentre study P Collin, K Kaukinen, H Vogelsang, I Korponay-Szabó, R Sommer, ... European Journal of Gastroenterology & Hepatology 17 (1), 85-91, 2005 | 304 | 2005 |
| Autoimmune hepatitis–current management and challenges K Zachou, P Muratori, GK Koukoulis, A Granito, N Gatselis, A Fabbri, ... Alimentary Pharmacology & Therapeutics 38 (8), 887-913, 2013 | 242 | 2013 |
| High prevalence of celiac disease in Italian general population U Volta, S Bellentani, FB Bianchi, G Brandi, L De Franceschi, L Miglioli, ... Digestive Diseases and Sciences 46 (7), 1500-1505, 2001 | 235 | 2001 |
| A multifaceted imbalance of T cells with regulatory function characterizes type 1 autoimmune hepatitis S Ferri, MS Longhi, C De Molo, C Lalanne, P Muratori, A Granito, ... Hepatology 52 (3), 999-1007, 2010 | 229 | 2010 |
| Celiac disease in autoimmune cholestatic liver disorders U Volta, L Rodrigo, A Granito, N Petrolini, P Muratori, L Muratori, ... American Journal of Gastroenterology 97 (10), 2609-2613, 2002 | 226 | 2002 |
| Contrast Ultrasound LI-RADS LR-5 Identifies Hepatocellular Carcinoma in Cirrhosis in a Multicenter Restropective Study of 1,006 Nodules E Terzi, M Iavarone, M Pompili, L Veronese, G Cabibbo, M Fraquelli, ... Journal of Hepatology 68 (3), 485-492, 2018 | 224 | 2018 |
| Autoimmune hepatitis in Italy: the Bologna experience P Muratori, A Granito, C Quarneti, S Ferri, R Menichella, F Cassani, ... Journal of Hepatology 50 (6), 1210-1218, 2009 | 180 | 2009 |
| RESORCE Investigators Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled … J Bruix, S Qin, P Merle, A Granito, YH Huang, G Bodoky, M Pracht, ... Lancet 389 (10064), 56-66, 2017 | 173 | 2017 |
| COVID‐19 and immunological dysregulation: can autoantibodies be useful? S Pascolini, A Vannini, G Deleonardi, M Ciordinik, A Sensoli, I Carletti, ... Clinical and translational science 14 (2), 502-508, 2021 | 169 | 2021 |
| Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up U Volta, A Granito, E Fiorini, C Parisi, M Piscaglia, G Pappas, P Muratori, ... Digestive Diseases and Sciences 53 (6), 1582-1588, 2008 | 167 | 2008 |
| New hallmark of hepatocellular carcinoma, early hepatocellular carcinoma and high-grade dysplastic nodules on Gd-EOB-DTPA MRI in patients with cirrhosis: a new diagnostic algorithm M Renzulli, M Biselli, S Brocchi, A Granito, F Vasuri, F Tovoli, ... Gut 67 (9), 1674-1682, 2018 | 166 | 2018 |
| Deamidated gliadin peptide antibodies as a routine test for celiac disease: a prospective analysis U Volta, A Granito, C Parisi, A Fabbri, E Fiorini, M Piscaglia, F Tovoli, ... Journal of Clinical Gastroenterology 44 (3), 186-190, 2010 | 157 | 2010 |
| The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome P Muratori, A Granito, G Pappas, GM Pendino, C Quarneti, R Cicola, ... Official journal of the American College of Gastroenterology| ACG 104 (6 …, 2009 | 146 | 2009 |
| VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: The ALICE‐1 study M Scartozzi, L Faloppi, G Svegliati Baroni, C Loretelli, F Piscaglia, ... International Journal of Cancer 135 (5), 1247-1256, 2014 | 143 | 2014 |
| Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis A Granito, L Bolondi The Lancet Oncology 18 (2), e101-e112, 2017 | 140 | 2017 |
| Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound M Galassi, M Iavarone, S Rossi, S Bota, S Vavassori, L Rosa, S Leoni, ... Liver International 33 (5), 771-779, 2013 | 138 | 2013 |
Paolo MuratoriMedicina InternaEmail verificata su unibo.it
